Oxford Covid Vaccine Phase-3 Trials Enrolment Complete: Serum Institute

Oxford Covid Vaccine Phase-3 Trials Enrolment Complete: Serum Institute Serum Institute of India (SII) and ICMR on Thursday announced the completion of enrolment process of 1,600 participants in the phase-III clinical trials for COVID-19 vaccine Covishield in the country.